Homocisteína y aterosclerosis: la tan esperada fase de los ensayos clínicos controlados. ¿Los multivitamínicos podrán reducir el riesgo de enfermedad coronaria? (Editorial) / Homocysteine and atherosclerosis: the so expected phase of controlled clinical trials. Will multivitamins be able to reduce the risk of coronary heart disease? (Editorial)
Rev. invest. clín
; Rev. invest. clín;52(3): 223-6, mayo-jun. 2000. CD-ROM
Article
in Es
| LILACS
| ID: lil-292124
Responsible library:
MX1.1
Search on Google
Index:
LILACS
Main subject:
Coronary Artery Disease
/
Homocysteine
/
Hyperlipidemias
Type of study:
Etiology_studies
/
Risk_factors_studies
Language:
Es
Journal:
Rev. invest. clín
Journal subject:
MEDICINA
Year:
2000
Type:
Article